Trials / Completed
CompletedNCT01379963
A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
Non-interventional Study of Six-month Retrospective Reporting of Hemoglobin Levels in Patients With Renal Anaemia Who Are Treated With MIRCERA® (Methoxy-polyethylene-glycol-epoetin Beta)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 780 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This retrospective observational study will evaluate the hemoglobin levels in patients with renal anemia over 6 months treatment with Mircera (methoxy polyethylene glycol-epoetin beta).
Conditions
Timeline
- Start date
- 2009-04-30
- Primary completion
- 2011-02-28
- Completion
- 2011-02-28
- First posted
- 2011-06-23
- Last updated
- 2017-07-13
- Results posted
- 2015-12-24
Locations
17 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT01379963. Inclusion in this directory is not an endorsement.